Skip to content

← All stories

Policy

BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?

1 source ·1 article ·Sep 4, 18:44 UTC

Covered by 1 outlet

All coverage · 1 article

Yahoo Finance News ·Sep 4, 18:44 UTC

BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?